Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01724450 | Carvedilol Effect in Preventing Chemotherapy - Induced Cardiotoxicity(Ceccy) | completed | Phase 3 | 200 | University of Sao PauloOTHER | 1 | Feb 5, 2018 | clinicaltrials |
| NCT02784730 | Iterative PICC Placement Versus Long Term Device(PICC One Day) | withdrawn | Phase 3 | 0 | Centre Leon BerardOTHER | 1 | Feb 5, 2018 | clinicaltrials |
| NCT00950300 | A Study to Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer | completed | Phase 3 | 596 | Hoffmann-La RocheINDUSTRY | 26 | Jan 23, 2018 | clinicaltrials |
| NCT01655992 | A Trial Comparing S1 Generic With Capecitabine in Metastatic Breast Cancer (MBC) | terminated | Phase 3 | 386 | Fudan UniversityOTHER | 1 | Jan 23, 2018 | clinicaltrials |
| NCT03404752 | Pegfilgrastim-gema Compared to Pegfilgrastim-roche for Prevention of Induced Neutropenia in Breast Cancer Patients. | unknown | Phase 3 | 120 | Gema Biotech S.A.INDUSTRY | 1 | Jan 19, 2018 | clinicaltrials |
| NCT00093795 | Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer | completed | Phase 3 | 4,894 | NSABP Foundation IncNETWORK | 1 | Jan 11, 2018 | clinicaltrials |
| NCT00516269 | Trial of a Sustained Release Methylphenidate in the Treatment of Fatigue in Cancer Patients | terminated | Phase 3 | 42 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 3, 2018 | clinicaltrials |
| NCT03385200 | KVUS at Neoadjuvant CTx of Breast Cancer | unknown | Phase 3 | 60 | RWTH Aachen UniversityOTHER | 1 | Dec 28, 2017 | clinicaltrials |
| NCT03373708 | Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast Cancer | unknown | Phase 2 / Phase 3 | 200 | Zhiyong YuOTHER | 0 | Dec 18, 2017 | clinicaltrials |
| NCT00003830 | Surgery to Remove Sentinel Lymph Nodes With or Without Removing Lymph Nodes in the Armpit in Treating Women With Breast Cancer | completed | Phase 3 | 5,611 | NSABP Foundation IncNETWORK | 3 | Dec 13, 2017 | clinicaltrials |
| NCT00009945 | Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer | completed | Phase 3 | 3,323 | NSABP Foundation IncNETWORK | 1 | Dec 13, 2017 | clinicaltrials |
| NCT00004205 | Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer(BIG 1-98) | completed | Phase 3 | 8,028 | ETOP IBCSG Partners FoundationNETWORK | 3 | Dec 12, 2017 | clinicaltrials |
| NCT01724242 | Vaginal DHEA for Women After Breast Cancer | withdrawn | Phase 2 / Phase 3 | 0 | Hadassah Medical OrganizationOTHER | 1 | Nov 28, 2017 | clinicaltrials |
| NCT03351062 | Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer | unknown | Phase 3 | 844 | Chinese Anti-Cancer AssociationOTHER | 1 | Nov 22, 2017 | clinicaltrials |
| NCT03349177 | Pathological Complete Response Rate in Locally Advanced Breast Cancer With FEC, EC-T, or TC as Neoadjuvant Chemotherapy | unknown | Phase 2 / Phase 3 | 200 | Zhiyong YuOTHER | 0 | Nov 21, 2017 | clinicaltrials |
| NCT02980965 | Neoadjuvant Chemo-endocrine Therapy Versus Chemotherapy Alone in ER-positive, HER2-negative Breast Cancer | completed | Phase 3 | 249 | Fudan UniversityOTHER | 1 | Nov 13, 2017 | clinicaltrials |
| NCT00382018 | S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells for Metastatic Breast Cancer Treated With Chemo | completed | Phase 3 | 624 | SWOG Cancer Research NetworkNETWORK | 1 | Nov 6, 2017 | clinicaltrials |
| NCT03319069 | Post Mastectomy Hypofractionated Radiotherapy in High Risk Breast Cancer | unknown | Phase 3 | 60 | Ahmed AhmOTHER | 1 | Oct 24, 2017 | clinicaltrials |
| NCT02483767 | Gonadotropin-Releasing Hormone Agonist for the Preservation of Ovarian Function During Chemotherapy in Premenopausal Breast Cancer(POF) | completed | Phase 3 | 98 | Peking Union Medical College HospitalOTHER | 0 | Oct 17, 2017 | clinicaltrials |
| NCT00408408 | Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery | unknown | Phase 3 | 1,206 | NSABP Foundation IncNETWORK | 3 | Sep 18, 2017 | clinicaltrials |
| NCT02768714 | Trial to Compare the Efficacy and Safety of Pegfilgrastim Biosimilar in Subjects With High Risk Stage Breast Cancer Receiving Chemotherapy | withdrawn | Phase 3 | 0 | Eurofarma Laboratorios S.A.INDUSTRY | 0 | Sep 15, 2017 | clinicaltrials |
| NCT00684216 | Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer | terminated | Phase 2 / Phase 3 | 10 | The Netherlands Cancer InstituteOTHER | 1 | Sep 14, 2017 | clinicaltrials |
| NCT03275727 | A Guided Internet-delivered Individually-tailored ACT-influenced CBT Intervention to Improve Psychosocial Outcomes in Breast Cancer(INNOVBC) | unknown | Phase 2 / Phase 3 | 128 | Linkoeping UniversityOTHER_GOV | 0 | Sep 8, 2017 | clinicaltrials |
| NCT00535418 | Optimal Duration of Pre-operative Treatment With Letrozole and to Correlate Clinical Efficacy With Appropriate Surrogate Markers | completed | Phase 2 / Phase 3 | 35 | Novartis PharmaceuticalsINDUSTRY | 0 | Sep 5, 2017 | clinicaltrials |
| NCT01516736 | Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim(PROTECT2) | completed | Phase 3 | 308 | SandozINDUSTRY | 8 | Aug 30, 2017 | clinicaltrials |
| NCT02001506 | Neoadjuvant Chemotherapy of 6 Cycles vs 8 Cycles in Node Positve Breast Cancer(Neo-shorter) | completed | Phase 3 | 250 | Asan Medical CenterOTHER | 1 | Aug 29, 2017 | clinicaltrials |
| NCT01712893 | Simultaneous Versus Sequential Use of Adjuvant Chemotherapy and GnRHa in Treating ER+,Premenopausal Breast Cancer | completed | Phase 3 | 216 | Fudan UniversityOTHER | 1 | Aug 25, 2017 | clinicaltrials |
| NCT01495650 | Effect of a Tailored Program of Physical Activity and Nutritional Counseling on Fatigue Reduction in Breast Cancer Patients Receiving an Adjuvant Treatment(APAD) | completed | Phase 3 | 240 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Aug 21, 2017 | clinicaltrials |
| NCT00775645 | S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, II, or IIIA Breast Cancer Undergoing Chemo | completed | Phase 3 | 437 | SWOG Cancer Research NetworkNETWORK | 1 | Aug 14, 2017 | clinicaltrials |
| NCT01735175 | Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta®(PROTECT-1) | completed | Phase 3 | 316 | SandozINDUSTRY | 6 | Aug 7, 2017 | clinicaltrials |
| NCT02286778 | Eradication of Malignant Carcinoma in the Breast Tissue | completed | Phase 2 / Phase 3 | 60 | Optimal Health ResearchOTHER | 0 | Aug 3, 2017 | clinicaltrials |
| NCT03085368 | A Randomized Controlled Trial of HER-2 Positive Breast Cancer Patients Treated With Lapatinib vs Herceptin | unknown | Phase 2 / Phase 3 | 482 | Peking Union Medical College HospitalOTHER | 1 | Jul 28, 2017 | clinicaltrials |
| NCT02125344 | A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto) | completed | Phase 3 | 961 | GBG Forschungs GmbHOTHER | 1 | Jul 13, 2017 | clinicaltrials |
| NCT02651610 | Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast Cancer | withdrawn | Phase 2 / Phase 3 | 0 | Peregrine PharmaceuticalsINDUSTRY | 1 | Jul 11, 2017 | clinicaltrials |
| NCT00789581 | A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer(TITAN) | completed | Phase 3 | 614 | SCRI Development Innovations, LLCOTHER | 2 | Jul 2, 2017 | clinicaltrials |
| NCT01222052 | 6xFU/Epirubicin/Cyclophosphamide (FEC) Compared to 3xFEC-3xDocetaxel in High-risk Node-negative Breast Cancer Patients(NNBC3-Europe) | unknown | Phase 3 | 4,150 | Martin-Luther-Universität Halle-WittenbergOTHER | 1 | Jun 26, 2017 | clinicaltrials |
| NCT00074152 | Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for LOcally Recurrent Breast Cancer(CALOR) | completed | Phase 3 | 162 | ETOP IBCSG Partners FoundationNETWORK | 10 | Jun 16, 2017 | clinicaltrials |
| NCT00266799 | The Efficacy and Safety of Pegylated Liposomal Doxorubicin Compared With Capecitabine as First Line Chemotherapy for Metastatic Breast Cancer (P04445/MK-2746-071) | completed | Phase 3 | 210 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Jun 8, 2017 | clinicaltrials |
| NCT02761460 | The Efficacy and Safety of PEG-rhG-CSF in Preventing Chemotherapy-induced Neutropenia | unknown | Phase 3 | 338 | wang shusenOTHER | 1 | Jun 1, 2017 | clinicaltrials |
| NCT01317108 | Prognostic and Predictive Impact of uPA/PAI-1(ChemoN0) | completed | Phase 3 | 689 | Universitätsklinikum Hamburg-EppendorfOTHER | 0 | May 25, 2017 | clinicaltrials |
| NCT01276938 | Exclusive Intraoperative Radiation Therapy for Breast Cancer | completed | Phase 2 / Phase 3 | 40 | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, ItalyOTHER | 1 | May 24, 2017 | clinicaltrials |
| NCT00041119 | Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer | completed | Phase 3 | 3,871 | Alliance for Clinical Trials in OncologyOTHER | 2 | May 18, 2017 | clinicaltrials |
| NCT00685256 | Standard Genetic Counseling With or Without a Decision Guide in Improving Communication Between Mothers Undergoing BRCA1/2 Testing and Their Minor-Age Children | completed | Phase 3 | 245 | Georgetown UniversityOTHER | 1 | May 17, 2017 | clinicaltrials |
| NCT00324324 | Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant | terminated | Phase 3 | 240 | OHSU Knight Cancer InstituteOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT00092196 | Study of MK0869 for the Prevention of Chemotherapy-Induced Nausea and Vomiting (0869-071)(COMPLETED) | completed | Phase 3 | 820 | Merck Sharp & Dohme LLCINDUSTRY | 0 | May 5, 2017 | clinicaltrials |
| NCT00863655 | Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole(BOLERO-2) | completed | Phase 3 | 724 | Novartis PharmaceuticalsINDUSTRY | 24 | May 2, 2017 | clinicaltrials |
| NCT00561119 | Maintenance Versus Observation After 6 Cycles of Gemcitabine Plus Paclitaxel in Pts With Advanced Breast Cancer | completed | Phase 3 | 326 | Samsung Medical CenterOTHER | 1 | May 1, 2017 | clinicaltrials |
| NCT00876486 | Evaluate the Efficacy and Safety of Genexol®-PM Compared to Genexol® in Recurrent or Metastatic Breast Cancer | completed | Phase 3 | 213 | Samyang Biopharmaceuticals CorporationINDUSTRY | 1 | May 1, 2017 | clinicaltrials |
| NCT00045032 | Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer(HERA) | completed | Phase 3 | 5,099 | Hoffmann-La RocheINDUSTRY | 33 | Apr 27, 2017 | clinicaltrials |
Data updated 24 days agoSource updated Feb 5, 2018source: clinicaltrials